Skip to main content
. 2007 Mar 20;151(2):237–252. doi: 10.1038/sj.bjp.0707158

Figure 2.

Figure 2

F15063 inhibits radioligand binding at 5-HT1A and D2 receptors. Competition-binding curves for F15063 in comparison with haloperidol and (±)8-OH-DPAT at: (a) human 5-HT1A receptors expressed in HeLa cells; (b) rat hippocampal 5-HT1A receptors; (c) human D2S receptors expressed in CHO cells; (d) rat striatal D2 receptors. Binding conditions are described in Tables 1 and 2 and values are mean±s.e.m. from three experiments performed in triplicate or in duplicate. Data from these experiments are shown in Tables 4 and 5.